Bollard Group LLC Repligen Corp Transaction History

Bollard Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $5,813 - $7,573	42 New	42 $6,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $59,507 - $79,532	-423 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $54,111 - $67,878	-300 Reduced 41.49%	423 $82,000
Q4 2020 Feb 04, 2021	BUY	$148.08 - $206.57 $44,424 - $61,971	300 Added 70.92%	723 $139,000
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $39,901 - $59,423	423 New	423 $52,000

526

59.2M

321K

667K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

Stay updated on Bollard Group LLC with notifications on news.